Zusammenfassung
In Deutschland sind ca. 800 Patienten mit homozygoter Erkrankung bekannt, die Anzahl der Träger liegt bei geschätzten 30.000. Die Patienten stammen vor allem aus Zentralafrika und arabischen Ländern, selten aus Griechenland und Süditalien.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Angastiniotis MA, Hadjiminas MG (1981) Prevention of thalassaemia in Cyprus. Lancet: 369–371
Angastiniotis M, Modell B, Englezos P, Boulyjenkov V., Prevention and csontrol of maemoglobinopathies. Bulletin of the World Health Organization 73 (3): 375–396
Bickel H, Guthrie R, Hammersen G (1980) Neonatal screening for inborn errors of metabolism. Heidelberg New York: Springer
Cao A, Pintus L, Lecca U, 011a G, Cossu P, Rosatelli C, Galanello R (1984) Review: Control of homozygous beta thalassemia by carrier screening and antenatal diagnosis in Sardinians. Clinical Genetics 26: 12–22
Gaston HM et al. (1986) Prophylaxis with oral penicilline in children with sickle cell anemia. New Engl J Med 314: 1593–1599
Goosenns M et al. (1983) Prenatal diagnosis of sickle cell anemia in the first trimester of pregnancy. New Engl J Med 309: 831–833
Kiernan KM, Vichinsky E, Lubin BH (1989) Experience with newborn screening using isoelectric focussing. Pediatrics 354
H. Reinhard, Modell B, Ward RHT, Rodeck C, Petrou M, Rairweather DVI, Varnavides LA, White JM (1984) Effect of fetal diagnostic testing on birth rate of thalassaemia major in Britain. Lancet (12): 1383–1386
Rowley PT, Loader S et al. (1991) Prenatal screening for hemoglobinopathies. A prospective regional trial. Am J Hum Gen 48: 439–446
Rucknagel DL (1983) A decade of screening in the hemoglobinopathies: is a national program to prevent sickle cell anemia possible? Am J Pad Hem Oncol 5: 373–377
Scott RB, Castro O (1979) Screening for sickle cell hemoglobinopathies. JAMA 241: 1145–1147
Sickle cell disease: (1993) screening, diagnosis, management and counseling in newborns and infants. Clinical practice guideline 6. AHCPR publication no 93–0562.Rockville, MD
Tsevat J, Wong JB, Pauker SG, Steinberg MH (1991) Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pediatrics 118: 546–554
Vichinsky E, Hurst D et al. (1988) Newborn screening for sickle cell disease: effect on mortality. Pediatrics 81: 749–755
Rights and permissions
Copyright information
© 2001 Springer-Verlag Wien
About this chapter
Cite this chapter
Reinhard, H. (2001). Hämoglobinopathien. In: Screening auf angeborene endokrine und metabole Störungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6252-1_38
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6252-1_38
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7260-5
Online ISBN: 978-3-7091-6252-1
eBook Packages: Springer Book Archive